Exide Starts NCM Sampling; FY27 Revenue Expected

Exide Industries Limited — Q1 FY27 Earnings Call (held Aug 03, 2026)

1. Overall Tone of Management: Optimistic

• Management highlights “strong performance” and “broad-based growth” with margin expansion despite cost and currency headwinds.
• On lithium-ion, they emphasize concrete progress: “first NCM cylindrical line commenced customer sample deliveries during the quarter” and “LFP prismatic line has also started sample supplies,” with an expectation that “revenue contribution…to commence during FY27 shortly.”
• They repeatedly frame risks as monitorable/temporary (“we continue to closely monitor,” “we expect it to pick up in the second half”).

2. Key Themes from Management Commentary

• Demand support post GST rationalization: Automotive and consumer demand remained supportive; “replacement market demand stayed robust.”
• Cost pressure from West Asia disruptions + FX: Input costs elevated due to “disruptions in West Asia and adverse currency movement,” partially offset by “calibrated price adjustments.”
• Core business momentum + margin resilience: Double-digit growth across major businesses; EBITDA margin expanded (despite headwinds) due to “cost excellence program” and “efficient supply chain.”
• Government tenders muted but expected to improve: “government tenders remained muted… though we expect it to pick up in the second half.”
• Exports rebound from low base: After 5 consecutive quarters of decline, exports grew “20% plus” on low base.
• Lithium-ion giga factory execution milestone: Equipment delivered/installed; utilities operational; customer sampling started (NCM cylindrical) and LFP prismatic sampling started; certifications/testing completed; “revenue contribution…to commence during FY27 shortly.”
• Capital intensity and funding: Equity investment in Exide Energy Solutions reached INR 4,902 crores as of July 31, including INR 100 crores in July.

3. Q&A Analysis

Theme A: Core lead-acid growth—volume vs pricing; contract wins

• Core question(s):
• Split of growth between volume vs pricing in Q1.
• Whether any new contract wins drove revenue.
• Whether full-year growth targets are achievable given base effects.
• Management response:
• Volume growth was also double-digit across businesses; examples: 4W replacement ~10%, 4W OEM ~21%, 2W OEM ~20%, solar ~12–14%.
• “There was no contract signed… ‘business as usual.’”
• Full-year guidance: management would not give explicit guidance, but implied percentage growth could benefit from low base; also noted Q1 seasonality is typically strongest.
• Evasive/partial/strong points:
• Strong clarity on no contract wins.
• Full-year outlook was non-committal (“I will not be able to give you a guidance”).

Theme B: Lithium-ion—yields, commercialization timing, and off-take commitments

• Core question(s):
• How yields are trending after sampling start; learnings from startup.
• When revenue will start; whether there are volume commitments from 2W/3W/other applications.
• Management response:
• Yields improving but “real yield will be visible when you run the plant at 3-shift operation.”
• Revenue expected “to commence during FY27 shortly.”
• No explicit volume commitments; instead: plan to load two lines (1 NMC + 1 LFP) “provided our yields improve.”
• Demand not expected to be an issue: markets already exist; imported-cell replacement is the thesis.
• Evasive/partial/strong points:
• No yield numbers disclosed (explicitly avoided).
• No quantified off-take commitments; relied on market readiness narrative.

Theme C: PLI/subsidies and pricing economics vs imported cells

• Core question(s):
• Whether Exide will pursue the reapplication for PLI (10 GWh opened).
• How pricing/margins work given lower yields/utilization at startup and import dynamics.
• Management response:
• Strategy not disclosed: “we are not supposed to tell you our strategy,” but they are “serious player just studying all the fine prints.”
• On margins: “too early… to comment on margins.”
• Pricing/import dynamics: export VAT reduced (9%→6%) but “will go away from 1st of January”; also argued Chinese factories are “fully utilized” so less appetite to dump/export at low prices.
• Evasive/partial/strong points:
• Clear refusal to discuss margins (consistent with prior calls’ “too early” stance).
• Provided specific policy/tax timeline (Jan 1 impact) and a demand-side argument (less dumping).

Theme D: Utilization, capex, and investment plan for FY27

• Core question(s):
• Whether utilization targets (25–30% first year) remain on track.
• FY27 investment plan and whether total Phase 1 capex changes.
• Progress on Hyundai/Kia co-investment line.
• Management response:
• Utilization: “We stand by that utilization” (25–30%); Line 3 expected to ramp faster due to shorter time-to-market.
• Capex: Board approval INR 1,400 crores for FY27; INR 100 crores already invested in July; remainder in upcoming months.
• Total Phase 1 investment: may change “plus/minus” due to currency; Phase 2 capex expected lower than Phase 1 (utilities already built).
• Hyundai/Kia: ongoing parallel discussion; “delays”; not expected this calendar year/fiscal year; co-investment line may be customization rather than full line.
• Evasive/partial/strong points:
• Investment plan is quantified for FY27, but total Phase 1 change remains non-committal (“might change a bit plus/minus”).

Theme E: Raw materials ecosystem—China controls, electrolyte sourcing, localization roadmap

• Core question(s):
• Whether raw materials will be sourced from China; any risk from export controls.
• Electrolyte sourcing strategy (import vs domestic).
• Localization roadmap and timing; target BOM localization.
• Management response:
• Raw materials: “still not from China” for some inputs (but later they state “electrolyte will be completely imported” initially).
• China export control: not a ban; “additional approvals”; they expect operational mitigation via higher inventory.
• Electrolyte: imported initially using tech partner supply chain; also piloting a large Indian manufacturer.
• Localization target: “50% to 60% of bill of material localized in next 2 to 3 years.”
• Evasive/partial/strong points:
• Some answers are internally nuanced (raw materials “not from China” vs electrolyte “completely imported”); management distinguishes components.
• No quantified inventory buffer or cost impact disclosed.

Theme F: Technology transfer risk / contingency if Chinese licenses restricted

• Core question(s):
• Whether Chinese government interferes with technology transfer; preparedness if licenses are blocked.
• Management response:
• They claim they are “lucky” because they completed tech tie-ups and factory setup before embargoes.
• Licensed “4 or 5 products”; pilot plant planned “end of this calendar year.”
• If licenses blocked: continue manufacturing those products and develop in-house know-how on pilot line.
• Strong points:
• Direct contingency plan; also notes sequencing advantage (main line first, pilot later).

4. Guidance / Outlook

Explicit guidance (quantitative)

• Q1 FY27 performance (reported, not guidance):
• Standalone revenue growth: +17.6%
• EBITDA: INR 655 crores (+19.5% YoY)
• EBITDA margin: 12.4% (up 20 bps YoY, ~70 bps sequential)
• Lithium-ion:
• FY27 capex/equity infusion approval: INR 1,400 crores (with INR 100 crores invested in July)
• Utilization target: “25% to 30%” for first year (reaffirmed)
• Line plan: start with 2 lines (1 NMC + 1 LFP) “provided yields improve”
• Inverter revenue share range: 15% to 25% (seasonal)
• Core pricing:
• Q1 price correction YoY: ~4% to 6% across categories
• Q2: no decision yet; likely dynamic stepwise approach (qualitative)

Implicit signals (qualitative)

• Demand outlook: supportive environment; replacement market robust; government tenders expected to pick up in second half.
• Core growth confidence: management suggests full-year “percentage growth” could be achievable due to low base, but avoids explicit guidance.
• Lithium-ion commercialization: revenue contribution expected “during FY27 shortly,” but margins/yields not quantified until 3-shift operations.
• Competitive pricing environment: expects less dumping due to Chinese factories being “fully utilized,” and import landed cost dynamics changing after Jan 1.

5. Standout Statements (direct / revealing)

• No contract-driven growth: “There was no contract signed.”
• Margin resilience despite headwinds: “Margin expansion despite cost and currency headwinds… driven by higher revenues, cost control… and a very efficient supply chain.”
• Lithium-ion execution milestone: “first NCM cylindrical line commenced customer sample deliveries during the quarter.”
• Yield disclosure restraint: “Yields are improving… the real yield will be visible when you run the plant at 3-shift operation.”
• Demand-side confidence for lithium: “Demand will not be an issue… this market already exists… it is just a switchover.”
• Pricing/margin timing: “too early… to comment on margins.”
• Import dynamics timeline: export VAT “will go away from 1st of January.”
• Localization roadmap: “50% to 60% of bill of material localized in next 2 to 3 years.”
• Contingency on tech licenses: “we have licensed 4 or 5 products… if… technology licenses… don’t come… these 4, 5 products will keep on manufacturing.”

6. Red Flags / Positive Signals

Positive signals
– Broad-based double-digit growth across major segments.
– Margin expansion while explicitly acknowledging cost/FX headwinds.
– Clear operational milestones in lithium-ion (equipment installed, utilities operational, sampling started).
– Reaffirmed utilization target (25–30%) and FY27 funding approval (INR 1,400 crores).

Red flags
– No quantitative lithium yield/margin guidance; repeated “too early” stance.
– No quantified off-take commitments; reliance on “market already exists” narrative.
– Some answers are component-specific and could confuse: “raw material still not from China” vs “electrolyte will be completely imported.”
– Full-year core guidance avoided despite analyst probing (“I will not be able to give you a guidance”).

7. Historical Comparison & Consistency Analysis (vs prior 3 calls)

Prior calls provided: Q4 FY26 (May 06 2026), Q3 FY26 (Feb 03 2026), Q2 FY26 (Nov 17 2025).

a. Change in Tone Over Time

• Current (Q1 FY27): More Optimistic
• Stronger emphasis on margin expansion and customer sampling already started.
• Less “cautiously optimistic” language than Q4 FY26.
• What changed:
• Q4 FY26: “cautiously optimistic” and focus on lead-acid outlook; lithium still in validation/sample stage.
• Q1 FY27: lithium has moved from “validation/samples” to “customer sample deliveries commenced,” and management is more confident on demand readiness.

b. Tracking Past Commitments vs Outcomes

• Lithium-ion sampling/revenue timing
• Past statement (Q4 FY26, May 06 2026): cylindrical lines expected to start customer sample delivery “around this month onwards.”
• What happened by Q1 FY27 (Aug 03 2026 call): “first NCM cylindrical line commenced customer sample deliveries during the quarter.”
• Status: ✅ Delivered (timing aligns with “around this month onwards” narrative).
• Utilization ramp target
• Past statement (Q2 FY26, Nov 17 2025): first year utilization “25% utilization” (and later “close to 25–30%”).
• Current (Q1 FY27): “stand by that utilization” 25–30%.
• Status: ✅ Delivered / maintained (no slippage mentioned).
• FY27 revenue guidance
• Past (Q4 FY26 / Q3 FY26): management avoided firm guidance; focused on monitoring and seasonality.
• Current: still avoids explicit full-year guidance.
• Status: ⏳ Consistent avoidance (not a miss, but no new commitment).

c. Narrative Shifts

• Exports: from “geopolitical/tariff barriers” and “work in progress” (Q2/Q3 FY26) to “after 5 consecutive quarters of decline, grew 20%+” (Q1 FY27). Narrative shifts from stabilization to rebound.
• Lithium-ion: narrative moved from “commissioning nearing completion / trials” (Q2/Q3 FY26) to “customer sampling started” and “revenue contribution to commence during FY27 shortly.”
• Government tenders: introduced as a specific near-term headwind in Q1 FY27 (“muted”), whereas earlier calls emphasized exports/telecom weakness more.

d. Consistency & Credibility Signals

• Medium credibility (improving but still cautious):
• Consistent on: “too early” for lithium margins; reliance on yield/3-shift operations.
• Consistent on: lead-acid margin resilience via cost excellence.
• Credibility improved because a key lithium milestone (customer sampling) appears to have occurred as expected.
• However, management continues to avoid quantitative lithium economics (yields, margins, off-take), limiting verifiability.

e. Evolution of Key Themes

• Demand (GST-driven): improving/positive across calls; Q2/Q3 FY26 had GST-related demand deferrals and later recovery; Q1 FY27 continues supportive environment.
• Margins: Q2/Q3 FY26 emphasized cost excellence offsetting commodity pressure; Q1 FY27 shows margin expansion despite cost/FX headwinds.
• Lithium-ion: steady progression—commissioning → internal validation → customer sampling → expected FY27 revenue.
• Policy risk / China controls: became more explicit in Q1 FY27 around export controls and localization roadmap (and electrolyte sourcing).

f. Additional Insights (cross-period intelligence)

• A risk that was previously more “macro/geopolitical” (exports, tariffs) is now complemented by a more operational supply-chain risk in lithium-ion: China export controls/approvals and electrolyte import dependency.
• Management’s lithium narrative is increasingly structured around process milestones (lines, sampling, certifications, 3-shift yield), but still avoids the hardest-to-verify metrics (yield %, margin $, off-take volumes).